Abouelfetouh Mahmoud M, Liu Lingling, Salah Eman, Sun Rui, Nan Sha, Ding Mingxing, Ding Yi
College of Veterinary Medicine, Huazhong Agricultural University, No. 1, Shizishan Street, Hongshan District, Wuhan 430070, China.
Department of Surgery, Radiology and Anaesthesiology, Faculty of Veterinary Medicine, Benha University, Moshtohor, Toukh 13736, Egypt.
Animals (Basel). 2021 Mar 6;11(3):723. doi: 10.3390/ani11030723.
Goats have been used as animal models in research and are increasingly kept as companion animals. However, information about effective anesthetic drugs is scarce in this species. The objective of this study was to evaluate the effect of xylazine premedication on alfaxalone induction. Twelve clinically healthy goats weighing 18.5 ± 2 kg were randomly assigned to two groups. Induction was performed with alfaxalone alone intravenously (ALF group) or with xylazine premedication before alfaxalone administration (XYL-ALF group). The quality of induction was scored, induction doses of alfaxalone were determined, and cardiorespiratory parameters and nociceptive thresholds were measured before any treatment(s) (baseline) and at 5, 15, 25 and 35 min after alfaxalone administration. The mean dose of alfaxalone required for induction in the ALF group was greater than that in the XYL-ALF group ( < 0.001). There were no significant changes in diastolic arterial pressure (DAP), mean arterial pressure (MAP) or systolic arterial pressure (SAP) compared to baseline in either group, while hemoglobin oxygen saturation (SpO) was lower from 5 to 25 min ( < 0.5) in the XYL-ALF group. The nociceptive threshold was significantly higher at 5 min in the XYL-ALF group than in the ALF group ( = 0.0417). Xylazine premedication reduced the required dose of alfaxalone for anesthetic induction and produced better antinociception than alfaxalone alone. In addition, the combination of xylazine and alfaxalone allowed for successful induction; however, oxygen supplementation is necessary to counteract xylazine-associated hypoxemia.
山羊已被用作研究中的动物模型,并且越来越多地被当作伴侣动物饲养。然而,关于该物种有效麻醉药物的信息却很少。本研究的目的是评估赛拉嗪预处理对阿法沙龙诱导麻醉的影响。将12只体重为18.5±2千克的临床健康山羊随机分为两组。一组通过静脉注射单独使用阿法沙龙进行诱导(ALF组),另一组在给予阿法沙龙之前先进行赛拉嗪预处理(XYL-ALF组)。对诱导质量进行评分,确定阿法沙龙的诱导剂量,并在任何治疗前(基线)以及阿法沙龙给药后5、15、25和35分钟测量心肺参数和痛觉阈值。ALF组诱导所需的阿法沙龙平均剂量高于XYL-ALF组(<0.001)。与基线相比,两组的舒张压(DAP)、平均动脉压(MAP)或收缩压(SAP)均无显著变化,而XYL-ALF组在5至25分钟时血红蛋白氧饱和度(SpO)较低(<0.5)。XYL-ALF组在5分钟时的痛觉阈值显著高于ALF组(=0.0417)。赛拉嗪预处理降低了麻醉诱导所需的阿法沙龙剂量,并且比单独使用阿法沙龙产生了更好的抗伤害感受作用。此外,赛拉嗪和阿法沙龙的联合使用实现了成功诱导;然而,需要补充氧气以对抗赛拉嗪相关的低氧血症。